Clinical Oncology - Issue Supplementum1/2019
Article
154
Metastatic Clear Cell Renal Carcinoma Without Evidence of a Primary Renal Tumour Mimicking Advanced Stage of Malignant Lung Tumour
M. Kolečková, T. Tichý, B. Melichar, L. Veverková, O. Hes, V. Kolek, Z. Kolář
157
Utilization of Next Generation Sequencing in Analysis of Circulating MicroRNAs as Predictive Biomarkers for Patients with Locally Advanced Rectal Carcinoma
T. Macháčková, T. Grolich, L. Fiala, V. Procházka, M. Škrovina, Z. Kala, O. Slabý
160
Chemoembolization for Treatment of Hepatocellular Carcinoma – National Registry-Based Analysis
T. Rohan, T. Andrašina, M. Uher, P. Matkulčík, J. Zavadil, M. Staňková, B. Čechová, L. Jandurová, V. Válek
164
Dynamic Changes in Circulating MicroRNA Levels in Liver Cancer Patients Undergoing Thermal Ablation and Transarterial Chemoembolization
J. Zavadil, J. Juráček, B. Čechová, T. Andrašina, O. Slabý, N. Goldberg
167
Encyclopedia of CLL Subsets – a Unique Bioinformatics Tool and Database for Analysis of Subsets of Stereotypical B-Cell Receptors in CLL
T. Reigl, K. Stránská, V. Bystrý, A. Krejčí, A. Grioni, Š. Pospíšilová, N. Darzentas, K. Plevová
171
Molecular Classification of Medullobastomas by Whole Genome Expression Profiling
H. Nosková, S. Adamcová, L. D. Radová Knoflíčková, Z. Pavelka, K. Vejmělková, K. Zitterbart, O. Slabý, J. Štěrba
174
Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection
N. A. Gabło, V. Procházka, J. Hlavsa, I. Kiss, J. Srovnal, Z. Kala, O. Slabý
Clinical Oncology
2019 Issue Supplementum1
Most read in this issue
- Metastatic Clear Cell Renal Carcinoma Without Evidence of a Primary Renal Tumour Mimicking Advanced Stage of Malignant Lung Tumour
- Encyclopedia of CLL Subsets – a Unique Bioinformatics Tool and Database for Analysis of Subsets of Stereotypical B-Cell Receptors in CLL
- Molecular Classification of Medullobastomas by Whole Genome Expression Profiling
- Analysis of Blood Plasma MicroRNAs to Enable Identification of Patients with Pancreatic Ductal Adenocarcinoma Who Will Benefit from Surgical Resection